Business / Finance

RSS

Capital Pro-Égaux enters into settlement agreement with Nobel Biocare

Capital Pro-Égaux Inc. (the "Company") (NEX: CPE.H) announces that its wholly owned subsidiary, Technique d'usinage Sinlab Inc. ("Sinlab"), has entered into a settlement agreement with Nobel Biocare AB; Nobel Biocare Italiana S.r.l.; Nobel Biocare Holding AG; Nobel Biocare Deutschland GmbH; Nobel Biocare Canada, Inc., a Canadian federal corporation; Biocad Médical Inc., a Quebec provincial corporation; Nobel Biocare USA, LLC, a Delaware limited liability company; and Nobel Biocare Procera, LLC, a Delaware limited liability company; (collectively "Nobel Entities") pursuant to which it settled civil actions in the United States, Canada, Italy and Germany involving the Nobel Entities and Sinblab.

5 Oct 2013

Merck Canada Awards $15.5M To Four Universities

...

4 Oct 2013

Designer Baby Patent Awarded To 23Andme

...

4 Oct 2013

Eppendorf Sponsoring Shared Lab Space At Cambridge, MA

Eppendorf North America is now a sponsor of LabCentral, a shared laboratory space designed to be a catalyst for entrepreneurs and life science startups. The 27,000 square-foot facility is slated for opening November 1, 2013, and will be located at Kendall Square, Cambridge, MA, in the Cambridge Biotech Innovation Hub.

From Eppendorf 4 Oct 2013

J&J's Janssen Companies Launch A Trio Of Collaborations

...

3 Oct 2013

X-Chem, Astrazeneca Expand Drug Discovery Collab

...

3 Oct 2013

Aaipharma Merges With Cambridge Major Laboratories

...

3 Oct 2013

CureVac collaborates with Janssen on development of influenza vaccine based on mRNA

CureVac, a clinical stage biopharmaceutical company that has pioneered the development of a new class of therapies and vaccines based on messenger RNA (mRNA), today announced that it has entered into a collaboration and licensing agreement with Janssen Pharmaceuticals, Inc. Under the agreement CureVac will collaborate with Crucell Holland B.V. (a member of the Janssen Pharmaceutical Companies) on the development of an influenza vaccine based on CureVac's RNActive® technology.

3 Oct 2013

Global leading supplier of pharmaceutical commercial packaging solutions, PCI, announces expansion of its personnel by 50

Packaging Coordinators, Inc. (PCI) is a global leading supplier of pharmaceutical commercial packaging solutions and clinical trials services. This week, they have announced that over the next six months the company will be further expanding its personnel by 50 at its Hay-on-Wye site. This latest recruitment drive comes after a successful apprenticeship enrolment programme, and following the placement of four Undergraduates from Swansea University; reinforcing the company’s commitment to supporting the development and education of the local community. Since April 2013, PCI has already recruited 40 staff members within the life sciences sector, signaling itself as one of the principal employers within the Life Sciences/Biotech industry in Wales.

From Packaging Coordinators Inc. (PCI) 3 Oct 2013

CaringBridge signs strategic agreement with Hallmark Cards

CaringBridge, a nonprofit social network that keeps families and loved ones connected during any type of health event, today announced a strategic agreement with Hallmark Cards, Inc., the world's leading greeting card brand. Through the collaboration, the two organizations will create co-branded content, product and services that will combine the two brands' insights and expertise to help people.

2 Oct 2013